News
With its sweeping beach, pretty Victorian cottages and rich royal heritage, there’s an unassuming elegance to unfashionable ...
With traditional pie and mash shops in jeopardy, a slice of London’s history is under threat of fading away The Standard's journalism is supported by our readers. When you purchase through links on ...
Recipe Master on MSN2h
Bacon Cheeseburger Mac and Cheese: The Ultimate Comfort Food Mash-UpThis Bacon Cheeseburger Mac and Cheese is a hearty, cheesy dream that blends two of the most iconic comfort foods—macaroni ...
Just a day after dropping a $625m cancer asset, GSK has inked a deal worth a potential $2bn to acquire Boston Pharmaceuticals ...
GSK has agreed to pay $1.2 billion upfront to acquire rights to efimosfermin from Cambridge, Massachusetts-based Boston ...
GSK to pay $1.2B upfront to Boston Pharmaceuticals for efimosfermin alfa, a MASH drug candidate. Deal includes $800M in ...
Explore more
3h
Daily Express US on MSNPutin can't stop wildfires threatening to engulf space station as firefighters sent to warAs flames encircle Russia's prized cosmodrome, locals recount scenes straight from a horror film while complaining of ...
Below is a brief background and tasting notes on the “Best of Class” and “Best of Category.” American Rye Whiskeys from the ...
The drugmaking giant plans to pay $1.2billion upfront to acquire Efirmosfermin from Boston Pharmaceuticals, followed by ...
GSK plans to purchase an experimental drug for the liver disease MASH from Boston Pharmaceuticals for $1.2 billion upfront.
GSK has already moved on from its decision to drop a cancer asset on Tuesday by snagging a late-stage liver disease candidate ...
Affecting up to 5% of the global population, SLD represents an area of significant unmet medical need with limited treatment optionsPhase II data show ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results